Fort Duncan Home Health And Hospice Care Medicare Approved Location: 3147 Megan Street Suite 1, Eagle Pass, Texas 78852 Phone: (830) 757-0966 |
Maverick Hospice Care Medicare Approved Location: 2822 N Veterans Blvd Suite B, Eagle Pass, Texas 78852 Phone: (830) 757-1362 |
Faith Home Hospice Care Medicare Approved Location: 2149 Del Rio Blvd Suite #207, Eagle Pass, Texas 78852 Phone: (830) 752-1655 |
News Archive
A new study by McGill University and Université de Montréal researchers has found that major anxiety and/or depression, can double a coronary artery disease patient's chances of repeated heart ailments.
eClinicalWorks®, a market leader in ambulatory clinical systems, today announced that Buffalo, New York's Catholic Independent Practice Association (CIPA) has selected eClinicalWorks unified electronic medical record (EMR) and practice management (PM) software for the Catholic Health System's network of ambulatory care offices and for select community physicians, purchasing 150 licenses. eClinicalWorks will also work with the IPA to connect into HEALTHeLINK, the local Regional Health Information Organization (RHIO).
"The state's public employee unions won a major victory this week when the Legislature abandoned efforts to allow cities and towns to trim generous health care benefits enjoyed by thousands of municipal employees, retirees, and elected officials. The decision by lawmakers not to address the issue in next year's budget means the Legislature will almost certainly not act on it this year, setting the stage for mayors and other municipal officials to take their case directly to voters in a ballot initiative for 2012" (Murphy, 6/25).
The Army will examine 190,000 files to see if it failed to give veterans the proper pension compensation for mental health problems. In Calif. one in 10 vets are uninsured.
Zafgen, Inc., a pharmaceutical company pioneering novel obesity therapeutics to help the body regain and sustain a lean, healthy state by targeting imbalances in fat metabolism, today announced data on ZGN-201, a prototype methionine aminopeptidase 2 inhibitor, for the treatment of obesity. Preclinical studies demonstrate MetAP2 inhibition eliminates excess body weight through the regulation of fat metabolism and food intake, and normalizes glucose tolerance in animal models.
› Verified 6 days ago